Pro-DexFRA:PDXN +8.82%63 Market Cap is €171.95 Mil as of Jul. 03, 2026. GuruFocus rates FRA:PDXN with a GF Score™ of 63/100 and a GF Value™ of €36.25 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Pro-Dex ranks better than 55.76% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pro-Dex's share price for the quarter that ended in Mar. 2026 was €41. Pro-Dex's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 3.20 Mil. Therefore, Pro-Dex's market cap for the quarter that ended in Mar. 2026 was €131.08 Mil.
Pro-Dex's quarterly market cap
increased
from Sep. 2025 (€93.29 Mil) to Dec. 2025 (€105.29 Mil) and
increased
from Dec. 2025 (€105.29 Mil) to Mar. 2026 (€131.08 Mil).
Pro-Dex's annual market cap
declined
from Jun. 2023 (€59.91 Mil) to Jun. 2024 (€55.49 Mil) but then
increased
from Jun. 2024 (€55.49 Mil) to Jun. 2025 (€123.92 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pro-Dex's Enterprise Value for Today is €179.28 Mil.
Pro-Dex (FRA:PDXN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pro-Dex Market Cap Related Terms
Pro-Dex Market Cap Historical Data
* Premium members only.
The historical data trend for Pro-Dex's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDXN vs KRMD, EMBC, SMTI: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Pro-Dex's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro-Dex Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Market Cap distribution charts can be found below:
* The bar in red indicates where Pro-Dex's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pro-Dex's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro-Dex (FRA:PDXN) has a Market Cap of €171.95 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pro-Dex and its competitors. According to the industry distribution chart, Pro-Dex ranks #384 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 44.2%.
Is Pro-Dex's Market Cap too high?
Pro-Dex's current Market Cap is €171.95 Mil. Based on the distribution chart, Pro-Dex ranks #384 out of 868 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Pro-Dex has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's Market Cap compare to KRMD and EMBC?
According to the Medical Devices & Instruments industry distribution chart, Pro-Dex ranks #384 out of 868 companies for Market Cap. This puts Pro-Dex in the upper half of its industry. The industry median Market Cap is 122.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.08, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pro-Dex and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro-Dex's current Market Cap is €171.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Based on GuruFocus' analysis, Pro-Dex (FRA:PDXN) is currently considered Significantly Overvalued. The stock's GF Value™ is €36.25, compared to a current price of €55.50 — trading 53.1% above its estimated fair value. The current Market Cap is €171.95 Mil. Pro-Dex's overall GF Score™ is 63/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pro-Dex (FRA:PDXN), the current Market Cap is €171.95 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro-Dex (FRA:PDXN) Overvalued in 2026?
Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued.
The current stock price of €55.50 is trading 53.1% above its estimated GF Value™ of €36.25.
GuruFocus considers Pro-Dex to be Significantly Overvalued.
Key valuation signals for FRA:PDXN:
Market Cap: €171.95 Mil
GF Value™: €36.25 vs. price of €55.50 (53.1% above fair value)
No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
63GF Score
Get the complete analysis for FRA:PDXN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDXN has been successfully added to your 
